NCT02341638 Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02307318 Heart and Hands Study II: A Retrospective Data Collection & Analysis Project Status COMPLETED Phase PHASE1/PHASE2
NCT02295475 Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome Status COMPLETED Phase PHASE4
NCT02270918 Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra Status COMPLETED Phase PHASE1
NCT02240953 Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis Status UNKNOWN Phase NA
NCT02198937 Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans Status TERMINATED Phase N/A
NCT02140801 Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel Status COMPLETED Phase PHASE4
NCT02064439 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) Status COMPLETED Phase PHASE3
NCT02055131 Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis Status UNKNOWN Phase PHASE4
NCT01988766 Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement Status COMPLETED Phase N/A
NCT01934725 Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01878916 Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs Status COMPLETED Phase N/A
NCT01855516 Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin Status COMPLETED Phase NA
NCT01835483 Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test Status COMPLETED Phase N/A
NCT01823185 Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Status UNKNOWN Phase PHASE4